Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 4Sarcoma 2Plasma cell 2Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Myeloid, Acute 387Leukemia 339Hematologic Neoplasms 313Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma 142Leukemia, Myelogenous, Chronic, BCR-ABL Positive 140Neoplasms 115Myelodysplastic Syndromes 108Multiple Myeloma 98Lymphoma, Non-Hodgkin 95Hodgkin Disease 60Lymphoma, Large B-Cell, Diffuse 56Lymphoma, Follicular 56Congenital Abnormalities 52Lymphoma, Mantle-Cell 49Burkitt Lymphoma 48Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Myeloproliferative Disorders 42Leukemia, Myelomonocytic, Chronic 41Breast Neoplasms 41Leukemia, Hairy Cell 36Recurrence 35Lung Neoplasms 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Neoplasms, Plasma Cell 31Lymphoma, T-Cell, Cutaneous 31Lymphoma, Large-Cell, Immunoblastic 31Waldenstrom Macroglobulinemia 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Castleman Disease × Other hematologic neoplasm × Clear all
NCT03717844 2025-11-20

Registry for Adults With Plasma Cell Disorders (PCD's)

UNC Lineberger Comprehensive Cancer Center

Recruiting
2,000 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Multiple Myeloma, POEMS Syndrome

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Peking University First Hospital

Recruiting
2,000 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡